Abstract:This study aims to develop an in vitro barrier effect test over biomimetic membrane, which is useful to establish the film forming ability of a substance-based medical device (SB-MD). The method contemplates a multiparametric approach including: i ) the measurement of the transmembrane passage of a molecular-like marker over a lipid-impregnated biomimetic membrane (simulating the skin and gastro-intestinal and buccal tissues) by using a static diffusion cell apparatus (Franz cell); and ii ) the evaluation of the integrity of the membrane (colorimetric test). In the first step, a series of lipid-impregnated biomimetic membranes (simulating gastro-intestinal, buccal, and skin tissues) were implemented and their permeability performance validated using model drugs (caffeine and acyclovir) by referring to literature data. As a result, the apparent permeability (P app ) of caffeine over the biomimetic gastro-intestinal membrane (P app = 30.5E-6 cm/s) was roughly comparable to the literature values obtained with Caco-2 cell line membrane (P app = 30.8E-6 cm/s) and with the Franz cell method (P app = 36.2E-6 cm/s). Acyclovir was shown to be a poorly permeable substance both in the literature and experimental data. Following this step, the permeability study was extended to both biomimetic buccal and skin (STRAT-M ® ) membranes: for caffeine, biomimetic gastro-intestinal membrane was the most permeable (P app = 30.5E-6 cm/s), followed by the buccal (P app = 18.2E-6 cm/s) then the skin (P app = 0.5E-6 cm/s) biomimetic membranes. In a second part of the work, the barrier effect test was developed following a similar permeability-like approach. The protocol was designed with the idea of assessing the capacity of a certain product to prevent the passage of caffeine across the biomimetic membrane with respect to a negative and positive control. The untreated membrane was the negative control, while membrane covered with a Vaseline film was the positive. As a last step, the developed barrier effect protocol was applied to an experimental gel-like SB-MD under development for the treatment of aphthae (Aphthae gel, an invented trade name), herein used as a case study. Regarding the results, Aphthae gel reduced the caffeine passage by 60.3%, thus highlighting its effectiveness to form a protective film. Overall, these results provide important knowledge and may pave the way for the use—including for industrial applications—of these simple but effective biomimetic membranes for carrying out high throughput screening necessary to design safe and effective SB-MDs before proceeding further with clinical trials, as requested by the regulations.

A Miniaturized Device for Biomembrane Permeation Analysis.

Multi-chamber microfluidic platform for high-precision skin permeation testing

Design, development, and validation of a novel static horizontally aligned drug diffusion cell (Shan DDC) for in vitro drug assessment

A Laminated Microfluidic Device for Comprehensive Preclinical Testing in the Drug ADME Process

The Development of an Artificial Skin Membrane Mimicking the Lipid Bilayer Structure for in Vitro Permeation Study

Safety and efficacy of substance-based medical devices: Design of an in vitro barrier effect test

Characterization of Drug Permeability in Caco-2 Monolayers by Mass Spectrometry on A Membrane-Based Microfluidic Device

Design of 3D printed insert for hanging culture of Caco-2 cells.

Three-dimensional Microporous Hollow Fiber Membrane Microfluidic Device Integrated with Selective Separation and Capillary Self-Driven for Point-of-care Testing.

Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays

Parafilm® M and Strat-M® as skin simulants in in vitro permeation of dissolving microarray patches loaded with proteins

Culture insert device with perfusable microchannels enhances in vitro skin model development and barrier function assessment

Assessing the Intestinal Permeability of Small Molecule Drugs Via Diffusion Motion on a Multidimensional Free Energy Surface.

Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs

Influence of in Vitro Methods, Receptor Fluids on Percutaneous Absorption and Validation of a Novel in Vitro Method.

Intestinal Permeability of Drugs in Caco-2 Cells Cultured in Microfluidic Devices

A Custom 3D Printed Permeate Probe Device for Enhanced Membrane Monitoring and Characterization

High-precision Approach Based on Microfluidic Perfusion Chamber for Quantitative Analysis of Biophysical Properties of Cell Membrane

Microfluidic Delivery Of Small Molecules Into Mammalian Cells Based On Hydrodynamic Focusing

Molecular Transport Through Membranes: Accurate Permeability Coefficients from Multidimensional Potentials of Mean Force and Local Diffusion Constants

The Development of an In Vitro Horizontal Diffusion Cell to Monitor Nasal Powder Penetration Inline